Syrris Releases Flow Chemistry Applications Video
News Sep 19, 2013
Syrris has released a Flow Chemistry Applications video succinctly describing the many and varied applications of this microchemistry technique.
The video shows how diverse fields of work, including synthetic chemistry, reaction optimization, hazardous reactions, nanoparticle synthesis, kinetic studies and biofuel production, are already benefitting from performing flow synthesis with Asia reactors.
It explains how the system’s wide pressure and temperature ranges allow solvents to be superheated, accelerating reaction rates up to a thousand times.
Process safety is also significantly enhanced as only small quantities of material react at any given time, minimizing exothermic reactions and the production of hazardous intermediates.
Viewers of the Flow Chemistry Applications video will discover that Asia systems are widely used in academia and chemistry-related industries, and are ideal for reaction optimization, allowing rapid variation of parameters such as reaction time, temperature, concentration and ratio of reagents, as well as offering easy process scale-up.
For automatic initiation of reaction protocols, worklists comprising hundreds of experiments can be created in minutes - or imported from Design of Experiment software - using automated Asia systems.
Quantitative analysis of each set of conditions can be performed automatically by diluting and diverting reaction aliquots to an LCMS or UPLC system using the Asia Sampler and Dilutor.
To view this informative video, please visit http://syrris.com/videos/flow-chemistry-videos/asia-flow-chemistry-applications-video.
Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes SynthesisNews
TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.READ MORE
Innovative ALS Therapy Startup Wins Golden Ticket Funding From AmgenNews
Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.READ MORE